Clinical trial
Window of Opportunity Study Targeting the Inflammatory Milieu
NCT01881048
Study timeline
Study start (actual)2009-12-08Date precision: day
Registry last updated2026-01-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage IA Breast Cancerunresolved
Stage IB Breast Cancerunresolved
Stage II Breast Cancerunresolved
Stage IIIA Breast Cancerunresolved
Stage IIIB Breast Cancerunresolved
Stage IIIC Breast Cancerunresolved
Stage IV Breast Cancerunresolved
Interventions
Omega-3 fatty acidDIETARY_SUPPLEMENT
CelecoxibDRUG · verified · RxNorm: celecoxib
Sponsors & collaborators
University of Colorado, Denverlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01881048 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.